Does Dr. GREGORY ESSELMAN have financial conflicts of interest?

Dr. GREGORY ESSELMAN (MD) has received a total of $422 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $422 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. GREGORY ESSELMAN?

According to CMS Open Payments data, Dr. GREGORY ESSELMAN received funding from OPTINOSE US ($200), GENZYME CORPORATION ($62), and REGENERON HEALTHCARE SOLUTIONS ($60).

Does Dr. GREGORY ESSELMAN receive research grants or speaking fees?

Dr. GREGORY ESSELMAN has received $422 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. GREGORY ESSELMAN

MDReal-Time Hydrated

Specialty: Otolaryngology, Otolaryngology/Facial Plastic Surgery

Practice Location: AIKEN, SC 20596

NPI Number: 1265479000

LIFETIME INDUSTRY VALUE

$422

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ESSELMAN is a verified Otolaryngology, Otolaryngology/Facial Plastic Surgery practitioner based in AIKEN, SC.

Between 2021 and 2024, Dr. ESSELMAN had an overall industry promotional and research financial footprint of $422 as recorded in the federal CMS Open Payments database.

$422 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ESSELMAN's primary funding source is OPTINOSE US, which accounts for $200 (representing 47.5% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

OPTINOSE US

Rank 1

$200

47.5%

GENZYME CORPORATION

Rank 2

$62

14.7%

REGENERON HEALTHCARE SOLUTIONS

Rank 3

$60

14.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.